FR2631238B1 - Baculovirus recombinant, procede de production de la proteine d'enveloppe du virus de l'encephalite japonaise a l'aide dudit virus, et cette proteine - Google Patents

Baculovirus recombinant, procede de production de la proteine d'enveloppe du virus de l'encephalite japonaise a l'aide dudit virus, et cette proteine

Info

Publication number
FR2631238B1
FR2631238B1 FR8906311A FR8906311A FR2631238B1 FR 2631238 B1 FR2631238 B1 FR 2631238B1 FR 8906311 A FR8906311 A FR 8906311A FR 8906311 A FR8906311 A FR 8906311A FR 2631238 B1 FR2631238 B1 FR 2631238B1
Authority
FR
France
Prior art keywords
virus
protein
encephalite
recombinant baculovirus
producing japanese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8906311A
Other languages
English (en)
Other versions
FR2631238A1 (fr
Inventor
Matsuura Yoshiharu
Yasui Kotaro
Sato Takanori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tokyo Metropolitan Institute for Neurosciences
Zeon Corp
Original Assignee
Tokyo Metropolitan Institute for Neurosciences
Nippon Zeon Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Metropolitan Institute for Neurosciences, Nippon Zeon Co Ltd filed Critical Tokyo Metropolitan Institute for Neurosciences
Publication of FR2631238A1 publication Critical patent/FR2631238A1/fr
Application granted granted Critical
Publication of FR2631238B1 publication Critical patent/FR2631238B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR8906311A 1988-05-12 1989-05-12 Baculovirus recombinant, procede de production de la proteine d'enveloppe du virus de l'encephalite japonaise a l'aide dudit virus, et cette proteine Expired - Fee Related FR2631238B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63115316A JP2511494B2 (ja) 1988-05-12 1988-05-12 日本脳炎ウイルス表面抗原蛋白質の製造法

Publications (2)

Publication Number Publication Date
FR2631238A1 FR2631238A1 (fr) 1989-11-17
FR2631238B1 true FR2631238B1 (fr) 1994-10-28

Family

ID=14659594

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8906311A Expired - Fee Related FR2631238B1 (fr) 1988-05-12 1989-05-12 Baculovirus recombinant, procede de production de la proteine d'enveloppe du virus de l'encephalite japonaise a l'aide dudit virus, et cette proteine

Country Status (5)

Country Link
US (1) US5229293A (fr)
JP (1) JP2511494B2 (fr)
KR (1) KR900018373A (fr)
FR (1) FR2631238B1 (fr)
GB (1) GB2218421B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02156896A (ja) * 1988-12-09 1990-06-15 Tokyo Met Gov Shinkei Kagaku Sogo Kenkyusho 日本脳炎ウイルスの非構成蛋白質の製造法
FR2665710A1 (fr) * 1990-08-10 1992-02-14 Pasteur Institut Baculovirus recombinant exprimant les proteines e et ns1 de virus appartenant aux flaviviridae ou de virus apparentes aux flaviviridae, applications diagnostiques et therapeutiques.
JPH0499485A (ja) * 1990-08-14 1992-03-31 Norin Suisanshiyou Kachiku Eisei Shikenjo 組換えバキュロウイルス
DE69435224D1 (de) * 1993-09-15 2009-09-10 Novartis Vaccines & Diagnostic Rekombinante Alphavirus-Vektoren
JPH07250127A (ja) * 1994-03-10 1995-09-26 Fujitsu Ltd 送信タイミング調整装置
AUPN503495A0 (en) * 1995-08-25 1995-09-21 Commonwealth Scientific And Industrial Research Organisation Recombinant helicoverpa baculoviruses expressing heterologous DNA
US7227011B2 (en) * 1998-06-04 2007-06-05 United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Nucleic acid vaccines for prevention of flavivirus infection
AU778988B2 (en) 1998-06-04 2004-12-23 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Nucleic acid vaccines for prevention of flavivirus infection
CA2359075A1 (fr) 1999-02-19 2000-08-24 Michigan State University Test d'antigenes pour la detection de myeloencephalite protozoaire equine dans le serum et le liquide cephalorachidien equins
US6307653B1 (en) * 1999-03-24 2001-10-23 Tellium, Inc Optical matrix protection system
AU5329300A (en) 1999-06-10 2001-01-02 Michigan State University Feline calicivirus isolated from cat urine and vaccines thereof
US7419668B1 (en) 1999-09-02 2008-09-02 Board Of Trustees Of Michigan State University Vaccine to control equine protozoal myeloencephalitis in horses
AU7108700A (en) 1999-09-02 2001-03-26 Michigan State University Vaccine to control equine protozoal myeloencephalitis in horses
CA2941182A1 (fr) * 2000-02-16 2001-08-23 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Flavivirus chimeriques avirulents et immunogenes
ZA200700168B (en) 2001-10-10 2010-02-24 Novo Nordisk As Remodeling and glycoconjugation of peptides
AU2004236174B2 (en) 2001-10-10 2011-06-02 Novo Nordisk A/S Glycopegylation methods and proteins/peptides produced by the methods
CN102180944A (zh) 2001-10-10 2011-09-14 诺和诺德公司 肽的重构和糖缀合
WO2005108560A2 (fr) * 2004-05-04 2005-11-17 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Synthese et purification de particules de type viral de virus du nil occidental
CN101563096A (zh) * 2005-07-28 2009-10-21 辉瑞产品公司 疫苗施用方法、新猫杯状病毒、及抗猫细小病毒和猫疱疹病毒的动物免疫方法
CN113637694A (zh) 2013-03-15 2021-11-12 武田疫苗股份有限公司 用于疫苗中的登革热病毒嵌合式构建物的组合物及方法
US11464815B2 (en) 2018-09-05 2022-10-11 Takeda Vaccines, Inc. Dengue vaccine unit dose and administration thereof
ES2908304T3 (es) 2018-09-05 2022-04-28 Takeda Vaccines Inc Dosis unitaria de vacuna contra el dengue y administración de la misma
US11426461B2 (en) 2018-09-05 2022-08-30 Takeda Vaccines, Inc. Methods for preventing dengue and hepatitis A

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127839B1 (fr) * 1983-05-27 1992-07-15 THE TEXAS A&M UNIVERSITY SYSTEM Procédé pour la préparation d'un vecteur recombinant d'expression de baculovirus
US4745051A (en) * 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
ZA848495B (en) * 1984-01-31 1985-09-25 Idaho Res Found Production of polypeptides in insect cells
IE60285B1 (en) * 1985-12-18 1994-06-29 Microgenesys Inc Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom
JPH0768267B2 (ja) * 1986-06-05 1995-07-26 財団法人阪大微生物病研究会 フラビウイルス抗原
EP0251467A3 (fr) * 1986-06-20 1988-07-20 Abbott Laboratories Compositions et méthodes de l'utilisation d'une protéine majeure de la capside extérieure (VP7) du rotavirus SA-11
NZ221702A (en) * 1986-09-08 1989-02-24 Bishop David H L Expression of human hepatitis b antigens in insects and cultured insect cells using recombinant baculoviruses
ZA876696B (en) * 1986-09-09 1988-05-25 Genetics Inst Method for producing a heterologous protein in insect cells
IL84154A0 (en) * 1986-10-16 1988-03-31 Microgenesys Inc Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same
JPH084508B2 (ja) * 1987-09-16 1996-01-24 国立予防衛生研究所長 組み換えワクチニアウイルス
JPH02156896A (ja) * 1988-12-09 1990-06-15 Tokyo Met Gov Shinkei Kagaku Sogo Kenkyusho 日本脳炎ウイルスの非構成蛋白質の製造法

Also Published As

Publication number Publication date
US5229293A (en) 1993-07-20
FR2631238A1 (fr) 1989-11-17
GB2218421A (en) 1989-11-15
GB2218421B (en) 1992-12-02
JP2511494B2 (ja) 1996-06-26
JPH01285198A (ja) 1989-11-16
GB8910381D0 (en) 1989-06-21
KR900018373A (ko) 1990-12-21

Similar Documents

Publication Publication Date Title
FR2631238B1 (fr) Baculovirus recombinant, procede de production de la proteine d'enveloppe du virus de l'encephalite japonaise a l'aide dudit virus, et cette proteine
HU901802D0 (en) Process for producing amino-acid derivatives
KR0140889B1 (en) Production of 2',3'-dideoxy-2',3'-didehydronucleosides
FR2634194B1 (fr) Procede de production d'alumines boehmitiques
GB8819453D0 (en) Production of bluetongue virus non-structural proteins using baculovirus expression vector
NZ233109A (en) Diagnosing alzheimer's disease using a beta-amyloid protein antibody
GB8823123D0 (en) Vibrating type transducer & manufacturing process thereof
HK100393A (en) Glass body formed from a vapor-derived gel and process for producing same
MA21645A1 (fr) Procede pour la preparation de nouveaux derives d'rtemisinine.
PT85461A (en) Process for preparing recombinant htlv-iii proteins and uses thereof
HU902037D0 (en) Process for producing amino-acid derivatives
FR2630735B1 (fr) Procede de preparations d'halogenophenols
DE3783401D1 (de) Medizinische roehre und herstellungsverfahren.
PT87207A (pt) Process for preparing recombinant htlv-iii proteins and uses thereof
MC2072A1 (fr) Procede pour la preparation d'une proteine hybride
FR2627079B1 (fr) Procede pour la fabrication d'une prothese biologique de tympan, et prothese biologique ainsi obtenue
FR2667603B1 (fr) Derives d'alkylpolysilanes et procede de fabrication d'un materiau ceramique les utilisant.
FR2649093B1 (fr) Procede de mise en forme d'une ceramique supraconductrice
HU902038D0 (en) Process for producing amino-acid derivatives
FI93118B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 1,4-diatsepiinijohdannaisten valmistamiseksi
HUT52523A (en) Process for producing amino-acid derivatives
GB8904426D0 (en) Improved baculovirus expression system capable of producing foreign gene proteins at high levels
FR2631962B1 (fr) Procede de production de la nitro-3 triazole-1,2,4 one-5
FI93010B (fi) Menetelmä 1,5-bentsotiatsepiinijohdannaisten valmistamiseksi
FR2667867B1 (fr) Procede pour la fabrication d'une enveloppe tubulaire de pelabilite amelioree.

Legal Events

Date Code Title Description
ST Notification of lapse
ST Notification of lapse